How one doctor's fight for his adopted daughter revealed the hidden flaws in modern healthcare—and what it means for all of ...

A Concordia-led research team has created one of the first reference charts showing how children's adipose (fat) and muscle ...

A new method for building growth charts for children with rare diseases is being integrated into DECIPHER to help clinicians ...

COLUMBUS —Ohio Rep. Angie King, R-Celina, announced her vote in support of the My Child-My Chart Act on Thursday. House Bill 162 would require a health care provider to ensure, under HIPAA, that a ...

The 137-year-old Kirloskar Group, one of India’s oldest engineering conglomerates, is embarking on a massive expansion across its four listed businesses — from engines and pig iron to compressors, ...

Growth charts for children with rare genetic disorders - giving healthcare professionals and families clearer guidance on how a child is developing - have been created by an international team, led by ...

Infants are generally expected to double their birth weight by five months and triple it by 12 months.

Objective: This study aimed to comprehensively analyze the global and Chinese burden of growth failure (GF) in children and adolescents from 1990 to 2021, focusing on mortality, disability-adjusted ...

BPG (Bates PanGulf Group), one of the region’s leading integrated marketing communications agencies and a member of the global WPP network, recently concluded its 29th annual offsite at the Yas Island ...

Dell on Tuesday nearly doubled its annual profit growth target for the next four years, betting on robust demand for its servers that power artificial intelligence workloads. The company, whose ...

Pediatric growth hormone deficiency (GHD) is a relatively rare condition, affecting an estimated 1 in 4,000- 10,000 children. Despite its rarity, GHD can significantly impact a child’s growth and ...

TOKYO, October 07, 2025--(BUSINESS WIRE)--RIBOMIC, Inc. (TOKYO:4591), a clinical-stage pharmaceutical company specializing in aptamer therapeutics, has conducted a Phase 2 clinical trial of ...